Biotech Values

[Rocky3]

From Barron's online:

"5 New Drugs That Could Be Blockbusters in 2014"

"Five Drugs to Watch


Drug Companies What It Treats 2020 Sales (est.) Stock **
Performance

idelalisib Gilead Sciences leukemia and NHL $2.5 billion 113.70%
RLX030 Novartis acute heart failure $1 billion 26%
Sovaldi/ledipasvir Gilead Sciences hepatitis C $9-$10 billion* 113.70%
nivolumab Bristol-Myers Squibb lung cancer $8 billion 59.20%
palbociclib Pfizer breast cancer $5.5 billion 20.20%

*Sales estimates for the hepatitis C combo pill are for 2017.
**Total return over the past 12 months."

Has description of each drug. Pretty big numbers for GILD's HCV and BMY's lung cancer.